A multi-institutional observational study of newly-diagnosed pulmonary mucosa-associated lymphoid tissue lymphoma in Japan (PALM-T study)
Not Applicable
- Conditions
- pulmonary mucosa-associated lymphoid tissue lymphoma
- Registration Number
- JPRN-UMIN000052577
- Lead Sponsor
- Mie University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with one or more of the following are excluded. 1. Patients who were diagnosed as not pulmonary MALT lymphoma based on diagnosis-related information 2. Patients who refused to consent to opt-out
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival of patients with newly-diagnosed pulmonary MALT lymphoma diagnosed between 2013 and 2022 at participating institutes
- Secondary Outcome Measures
Name Time Method Clinical features, treatment choice, toxicity, and risk factors affecting survival in pulmonary MALT lymphoma patients diagnosed between 2013 and 2022 at participating institutes